ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES

Authors : Oya GÜVEN, Lale TUNA, İbrahim Atakan GEÇİCİ, Zeynep Sümeyye DURGUN, Ömer IŞIK

Pages : 79-81

Doi:10.33706/jemcr.1089785

View : 18 | Download : 6

Publication Date : 2022-09-30

Article Type : Other Papers

Abstract :Introduction: Although the most prominent effect of Corona disease, respiratory disease it disrupts the vascular structure and causes vascular occlusion. Intravascular coagulation, has also begun to be observed in people who have been vaccinated. Therefore, clinicians had to add anti-coagulants or antiaggregants to the treatment. Case Reports: In this article; We will try to present the patient who developed arterial and venous embolism after BioNTech vaccine. These patients without known vascular disease responded well to treatment. Conclusion: The rate of sickness dropped after the vaccine was discovered to be the most effective strategy to protect against Covid-19. It was discovered that vaccinated patients exhibited symptoms similar to corona disease but had a moderate course.
Keywords : Covid 19, arterial embolism, venous embolism, BioNTech, vaccine